FIELD: medicine. SUBSTANCE: solution comprises the following components, mM/l: sodium chloride, 100.0-117.0; potassium gluconate, 12.0-17.0; calcium gluconate, 1.2-2.0; magnesium sulfate, 8.0-32.0; trihydroximethylaminomethane, 2.0-3.0; local anesthetic, 0.33-1.66; phenothiazine derivative, 0.01-0.04; purine derivative, 1.0-2.0; polyglucine, the balance. EFFECT: extended term of conservation of live organs and eliminated irreversible damage during subsequent reperfusion.
Title | Year | Author | Number |
---|---|---|---|
PRESERVATIVE SOLUTION FOR TRANSPLANTS | 1997 |
|
RU2140152C1 |
OVARIAN PRESERVATION METHOD | 2023 |
|
RU2822518C1 |
SOLUTIONS FOR TRANSPLANTS OF ORGANS AND METHOD OF TRANSPLANTING ORGANS | 1995 |
|
RU2161405C2 |
METHOD OF ORGAN TRANSPLANTATION | 1994 |
|
RU2074646C1 |
METHOD OF DETERMINING SUITABILITY OF TRANSPLANT FOR GRAFTING | 0 |
|
SU1496740A1 |
METHOD FOR TRANSPLANTING NEPHROLYMPHATIC COMPLEX | 1992 |
|
RU2063172C1 |
METHOD FOR RENAL TRANSPLANTATION | 2003 |
|
RU2271755C2 |
METHOD OF REANIMATION OF HEART | 0 |
|
SU1011127A1 |
WATER-BASE BLOOD SUBSTITUTE SOLUTION, METHOD OF ITS PREPARING | 1994 |
|
RU2142282C1 |
PERFUSION METHOD AND PERFUSION SYSTEM DEVICE FOR DONOR HEART PRESERVATION | 2023 |
|
RU2815290C1 |
Authors
Dates
1995-01-09—Published
1992-02-10—Filed